IRSA Inversiones y Representaciones Sociedad Anónima stock: fair value
IRSThe fair value of IRSA Inversiones y Representaciones Sociedad Anónima under our model is $9.67, the price is 25% above.
The fair value is an estimate from our model, not a price target.
Daily figure as of 13 Nov 2026
Valuation signal
Modestly overvaluedIn our model the price counts as cheap below $6.91 and expensive above $16.12 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $3.10 (cash-flow model) and $16.25 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 25%. At 26% the fair value would be $9.61, at 24% it would be $9.75.
Where the number comes from
Half from the cash-flow model, half from earnings times the industry P/E (13.4).
Ten-year cash-flow model from smoothed free cash flow and its past growth until it reaches 3.8%. Discounted at 25.0% (government bond yield 3.8% plus beta 1.52 times a risk premium of 13.9%); no analyst estimates were available.
Calculate with your own assumptionsThe calculation step by step
With these figures the cash flow model arrives at $3.10 per share: free cash flow for the next ten years, each year discounted to today at 25.0%, plus the terminal value for the years after. The table explains the calculation; it is not a recommendation.
Calculation as a table
| Year | Free cash flow | Source | Discount factor | Present value (discounted at 25.0%) |
|---|---|---|---|---|
| 2027 | ARS 121.82B | extrapolated at −6.8% | 0.8000 | ARS 97.45B |
| 2028 | ARS 117.42B | extrapolated at −3.6% | 0.6400 | ARS 75.14B |
| 2029 | ARS 115.8B | extrapolated at −1.4% | 0.5119 | ARS 59.28B |
| 2030 | ARS 116.01B | extrapolated at 0.2% | 0.4095 | ARS 47.51B |
| 2031 | ARS 117.49B | extrapolated at 1.3% | 0.3276 | ARS 38.49B |
| 2032 | ARS 119.89B | extrapolated at 2.0% | 0.2621 | ARS 31.42B |
| 2033 | ARS 122.99B | extrapolated at 2.6% | 0.2097 | ARS 25.79B |
| 2034 | ARS 126.62B | extrapolated at 2.9% | 0.1677 | ARS 21.24B |
| 2035 | ARS 130.69B | extrapolated at 3.2% | 0.1342 | ARS 17.54B |
| 2036 | ARS 135.14B | extrapolated at 3.4% | 0.1073 | ARS 14.51B |
| Step | Value |
|---|---|
| Sum of present values (ten years) | ARS 428.37B |
| Terminal value: cash flow 2036 × (1 + 3.8%) / (25.0% − 3.8%) | ARS 662.66B |
| Present value of terminal value (× 0.1073) | ARS 71.13B |
| Equity value (sum plus present value of terminal value) | ARS 499.49B |
| Shares (diluted) | 8.37M |
| Value per share (equity value divided by shares) | ARS 59,659.60 |
| Per share as traded (converted ÷ 19,272) | $3.10 |
| Earnings per share, last twelve months | $1.21 |
| × 13.4 (industry P/E) | $16.25 |
| Fair value (average of both parts) | $9.67 |
The model uses free cash flow after interest, which belongs to shareholders, discounted at the cost of equity. Net debt is therefore not deducted again.
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 30 Jun 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 3 Nov 2026)
- Valuation signal Fairly valued since 8 Nov 2026, previously Undervalued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.
